PCI Biotech: Independent Data Monitoring Committee recommends continuation of two treatments in the RELEASE trial Guest UserDecember 13, 2021
PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments Guest UserNovember 30, 2021
PCI Biotech: Presentation of fimaCHEM for bile duct cancer at IPA masterclass series Guest UserNovember 8, 2021
PCI Biotech: US patent for the vaccine technology (fimaVACC) in combination with checkpoint inhibitors Guest UserMay 31, 2021
PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer Guest UserMay 28, 2021
